Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1035219-96-5 | MDL No. : | MFCD14706758 |
Formula : | C6H5BrN2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FUSXFJPOPDRDHZ-UHFFFAOYSA-N |
M.W : | 233.09 | Pubchem ID : | 52988181 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 49.58 |
TPSA : | 70.23 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.54 cm/s |
Log Po/w (iLOGP) : | 1.53 |
Log Po/w (XLOGP3) : | 1.66 |
Log Po/w (WLOGP) : | 0.81 |
Log Po/w (MLOGP) : | 0.4 |
Log Po/w (SILICOS-IT) : | 3.01 |
Consensus Log Po/w : | 1.48 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.67 |
Solubility : | 0.501 mg/ml ; 0.00215 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.75 |
Solubility : | 0.416 mg/ml ; 0.00178 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.92 |
Solubility : | 0.278 mg/ml ; 0.00119 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.6 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With copper(ll) bromide; isopentyl nitrite In acetonitrile at 20℃; for 1.5 h; | A mixture of intermediate 3 (8 g, 39.8 mmol), copper (II) bromide (10.43 g, 46.68 mmol) and 3-methyl-l-nitrosooxy-butane (6.8 g, 58.35 mmol) in ACN (100 mL) was stirred at room temperature for 1.5 hours. The solvent was evaporated in vacuo. The residue thus obtained was dissolved in AcOEt and washed with H20. The organic layer was separated, dried (Na2S04), filtered and the solvents evaporated in vacuo to yield 5 g (55percent) of intermediate 4 that was used in the next step without further purification. |
36% | With copper(ll) bromide In tetrahydrofuran at 20℃; for 12 h; | Step ii: 2-bromo-6,7-dihydrothiazolo[5,4-clpyridin-4(5H)-one To a 50 mL round bottom flask, were added 2-amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)- one (0.4 g, 0.0023 mol) and THF (10 mL). To the same flask, amyl nitrite (1.6 mL) and copper (II) bromide (0.4 g) were added. The reaction mixture was stirred at RT for 12 h. The reaction mixture was diluted with ethyl acetate and washed with water. The organic layer was separated, washed with brine and dried over anhydrous sodium sulfate. The solvent was evaporated under reduced pressure to get crude product. The crude product was purified by column chromatography using 60-120 silica gel and 50 percent ethyl acetate in hexane to get the title compound [0.2 g, 36 percent]. LC-MS: 232.0 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With copper(ll) bromide; isopentyl nitrite In acetonitrile at 20℃; for 1.5 h; | A mixture of intermediate 4 (8 g, 39.8 mmol), copper (II) bromide (10.43 g, 46.68 mmol) and 3-methyl-l-nitrosooxy-butane (6.8 g, 58.35 mmol) in ACN (100 mL) was stirred at room temperature for 1.5 hours. The solvent was evaporated in vacuo. The residue thus obtained was dissolved in AcOEt and washed with H20. The organic layer was separated, dried (Na2S04), filtered and the solvent evaporated in vacuo to yield 5 g (55percent) of intermediate 6 that was used in the next step without further purification. |
[ 949922-52-5 ]
2-Bromo-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride
Similarity: 0.85
[ 143150-92-9 ]
2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
Similarity: 0.83
[ 365996-06-1 ]
tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
Similarity: 0.72
[ 1093106-54-7 ]
1-(2-Bromo-4-methylthiazol-5-yl)ethanone
Similarity: 0.71
[ 496062-16-9 ]
2-Bromo-4-(2-hydroxyethyl)-5-methylthiazole
Similarity: 0.68
[ 26493-11-8 ]
2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one
Similarity: 0.80
[ 365996-06-1 ]
tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
Similarity: 0.72
[ 848499-31-0 ]
2-Bromo-thiazole-5-carboxamide
Similarity: 0.67
[ 1251009-79-6 ]
tert-Butyl (2-bromo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)carbamate
Similarity: 0.63
[ 1253654-37-3 ]
tert-Butyl 2-bromo-6,7-dihydrothiazolo[4,5-c]pyridine-5(4H)-carboxylate
Similarity: 0.60
[ 949922-52-5 ]
2-Bromo-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine hydrochloride
Similarity: 0.85
[ 143150-92-9 ]
2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
Similarity: 0.83
[ 26493-11-8 ]
2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one
Similarity: 0.80
[ 365996-06-1 ]
tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
Similarity: 0.72
[ 259809-24-0 ]
5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine
Similarity: 0.72